An NK-like CAR T cell transition in CAR T cell dysfunction
Charly R. Good(University of Pennsylvania), Carl H. June(University of Pennsylvania), Steven Μ. Albelda(University of Pennsylvania), Shunichiro Kuramitsu(University of Pennsylvania), Philipp C. Rommel(University of Pennsylvania), Greg Donahue(University of Pennsylvania), Shelley L. Berger(University of Pennsylvania), Sangya Agarwal(Amgen (United States)), János L. Tanyi(Penn Center for AIDS Research), Nils Wellhausen(University of Pennsylvania), Mark H. O’Hara(University of Pennsylvania), Simon F. Lacey(University of Pennsylvania), Karl M. Glastad(Georgia Institute of Technology), Yujie Ma(University of Pennsylvania), Max W. Richardson(University of Pennsylvania), Keisuke Watanabe(Saitama Red Cross Hospital), M. Ángela Aznar(University of Pennsylvania), Nathan Singh(Unknown), Sònia Guedan(Fundació Clínic per a la Recerca Biomèdica), Lifeng Tian(Parker Institute for Cancer Immunotherapy), Regina M. Young(University of Pennsylvania), Stephen J. Schuster(Hospital of the University of Pennsylvania), Katherine A. Alexander(University of Pennsylvania), Austin K. Rennels(University of Pennsylvania), Marco Ruella(Parker Institute for Cancer Immunotherapy), Kenichi Ishiyama(University of California, San Francisco), Zhen Zhang(University of Pennsylvania), Lewis L. Lanier(Universidad Católica de Santa Fe), Edmund K. Moon(University of Pennsylvania), Parisa Samareh(University of Pennsylvania)
Cited by 398
Related Papers
Deep immune profiling of COVID-19 patients reveals distinct immunotypes with therapeutic implications
|Science|2020|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
Adhesion molecules and inflammatory injury
|The FASEB Journal|1994|1k
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940